Simplex Trading
MLNT

Simplex Trading’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Simplex Trading’s Portfolio MLNT Stock Details MLNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-61
Closed -$3K – 8719
2019
Q4 		$3K Buy
61
+46
+307% +$112 ﹤0.01% 6934
2019
Q3 		$5K Sell
15
-48
-76% -$173 ﹤0.01% 6653
2019
Q2 		$41K Buy
63
+53
+530% +$202 ﹤0.01% 5042
2019
Q1 		$3K Buy
+10
New +$54 ﹤0.01% 6731
2018
Q4 		– Sell
-10
Closed -$20K – 8283
2018
Q3 		$20K Hold
10
– – ﹤0.01% 5973
2018
Q2 		$33K Sell
10
-1
-9% -$36 ﹤0.01% 5468
2018
Q1 		$27K Sell
11
-24
-69% -$1.58K ﹤0.01% 3076
2017
Q4 		$10K Buy
+35
New +$2.59K ﹤0.01% 3937

Simplex Trading's MLNT Position: Q2 2019 in Review

Simplex Trading sold out of Melinta Therapeutics, Inc. Common Stock (MLNT) in Q2 2019, closing a stake of 892 shares — an estimated $3.4K sold.

Simplex Trading first reported a position in MLNT in Q2 2018 and held it in 3 quarters. The position peaked at $3K in Q1 2019. 53 funds tracked by Wall St. Rank hold MLNT as of Q2 2019.

  • Simplex Trading reported no remaining Melinta Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Simplex Trading sold 892 Melinta Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $3.4K.
  • Simplex Trading first reported a position in Melinta Therapeutics, Inc. Common Stock in Q2 2018 and held it in 3 quarters.
  • Simplex Trading's Melinta Therapeutics, Inc. Common Stock position peaked at $3K in Q1 2019.
  • 53 funds tracked by Wall St. Rank held Melinta Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Simplex Trading's 13F filing for Q2 2019, filed 26 Jul 2019.